Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3740618019 | Hydralazine and hydrochlorothiazide and reserpine only product in oral dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3740619010 | Product containing only hydralazine and hydrochlorothiazide and reserpine in oral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Hydralazine and hydrochlorothiazide and reserpine only product in oral dose form | a pour principe actif (attribut) | Hydralazine (substance) | true | Inferred relationship | Some | 1 | |
Hydralazine and hydrochlorothiazide and reserpine only product in oral dose form | a pour principe actif (attribut) | Reserpine (substance) | true | Inferred relationship | Some | 2 | |
Hydralazine and hydrochlorothiazide and reserpine only product in oral dose form | est un(e) (attribut) | Hydralazine- and hydrochlorothiazide- and reserpine-containing product in oral dose form | true | Inferred relationship | Some | ||
Hydralazine and hydrochlorothiazide and reserpine only product in oral dose form | a pour principe actif (attribut) | Hydrochlorothiazide (substance) | true | Inferred relationship | Some | 3 | |
Hydralazine and hydrochlorothiazide and reserpine only product in oral dose form | Count of base of active ingredient | trois | false | Inferred relationship | Some | ||
Hydralazine and hydrochlorothiazide and reserpine only product in oral dose form | est un(e) (attribut) | Product containing only hydralazine and hydrochlorothiazide and reserpine (medicinal product) | true | Inferred relationship | Some | ||
Hydralazine and hydrochlorothiazide and reserpine only product in oral dose form | a une forme pharmaceutique (attribut) | forme orale | true | Inferred relationship | Some | ||
Hydralazine and hydrochlorothiazide and reserpine only product in oral dose form | Plays role | Diuretic therapeutic role | true | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet | est un(e) (attribut) | True | Hydralazine and hydrochlorothiazide and reserpine only product in oral dose form | Inferred relationship | Some |
This concept is not in any reference sets